Pentostatin — CAS 53910-25-1

Pentostatin (2'-Deoxycoformycin) is a potent antineoplastic agent that acts as a purine analogue and inhibitor of adenosine deaminase (ADA). Mediocon Inc manufactures this high-purity oncology API at its GMP-certified facility in Aurangabad, Maharashtra, India. Pentostatin is used in the treatment of hairy cell leukemia and has demonstrated efficacy in other lymphoid malignancies. Its mechanism involves ADA inhibition leading to accumulation of toxic deoxyadenosine in lymphocytes.

• Hairy cell leukemia (HCL) treatment — first-line therapy
• Chronic lymphocytic leukemia (CLL) in refractory cases
• Cutaneous T-cell lymphoma management
• Graft-versus-host disease (GvHD) prophylaxis research

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support